Lam Research director sells 18,282 shares in plan trade

Lam Research Corp director Abhijit Y. Talwalkar executed an open-market sale of 18,282 shares of Common Stock on July 13, 2026 at $335.0000 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026.

Rhea-AI Filing Summary

Lam Research Corp director Abhijit Y. Talwalkar executed an open-market sale of 18,282 shares of Common Stock on July 13, 2026 at $335.0000 per share, pursuant to a Rule 10b5-1 trading plan adopted on March 11, 2026. Following the transaction, he directly owns 87,142 shares, which include shares subject to unvested restricted stock units.

Insider Trade Summary 10b5-1

Net Seller: 18,282 shares

Net Sell 1 txn

Insider TALWALKAR ABHIJIT Y

Role Director

Sold 18,282 shs ($6.12M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	18,282	$335.00	$6.12M

Holdings After Transaction: Common Stock — 87,142 shares (Direct)

Footnotes (2)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2026.
2. F2. The amount reported includes shares subject to unvested restricted stock units.

Key Figures

Shares sold: 18,282 shares Sale price per share: $335.0000 per share Total shares following transaction: 87,142 shares +2 more

5 metrics

Shares sold 18,282 shares Common Stock sold on 2026-07-13 in an open-market transaction

Sale price per share $335.0000 per share Price for Lam Research Common Stock sale on 2026-07-13

Total shares following transaction 87,142 shares Common Stock directly owned by Abhijit Y. Talwalkar after the sale, including unvested RSUs

Net insider selling shares 18,282 shares Net sell volume in this Form 4 per transaction summary

Rule 10b5-1 plan adoption date March 11, 2026 Date the reporting person adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, restricted stock units, open-market sale

3 terms

Rule 10b5-1 trading plan regulatory

"This transaction was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units financial

"The amount reported includes shares subject to unvested restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

open-market sale financial

"open-market sale or private transaction of Common Stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Lam Research Corp (LRCX) disclose for Abhijit Y. Talwalkar?

Lam Research Corp reported that director Abhijit Y. Talwalkar sold 18,282 shares of Common Stock on July 13, 2026 at $335.0000 per share in an open-market transaction executed under a Rule 10b5-1 trading plan.

How many Lam Research (LRCX) shares does Abhijit Y. Talwalkar hold after this Form 4 sale?

After the reported sale, Abhijit Y. Talwalkar directly holds 87,142 Lam Research shares. This amount, according to the disclosure, includes shares subject to unvested restricted stock units, reflecting both vested and certain unvested equity awards.

At what price did Abhijit Y. Talwalkar sell his Lam Research (LRCX) shares?

The disclosed transaction shows a sale price of $335.0000 per share for Lam Research Common Stock. All 18,282 shares covered by this Form 4 were sold at this price in an open-market sale or private transaction, as indicated.

Was the Lam Research (LRCX) insider sale by Abhijit Y. Talwalkar made under a Rule 10b5-1 plan?

Yes. A footnote explains the sale was effected pursuant to a Rule 10b5-1 trading plan that Abhijit Y. Talwalkar adopted on March 11, 2026, indicating the trades were pre-arranged rather than discretionary at the time of execution.

What type of transaction is reported in this Lam Research (LRCX) Form 4 filing?

The Form 4 reports an open-market sale of Lam Research Common Stock, coded as “S” for sale. It involves non-derivative securities only, with no option exercises or derivative transactions disclosed in this particular filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/14/2026 - 12:56 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TALWALKAR ABHIJIT Y

(Last) (First) (Middle)

C/O LAM RESEARCH CORPORATION

4650 CUSHING PARKWAY

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LAM RESEARCH CORP [ LRCX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/13/2026		S		18,282(1)	D	$335	87,142(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2026.

2. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	Marta Woods by Power of Attorney	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)